Neoadjuvant Use of Lenvatinib in Locally Advanced Papillary Thyroid Carcinoma Involving Critical Vessels
International Journal of Endocrine Oncology · 2020-12 · 7 (3)
DOI: 10.2217/ije-2020-0014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrine Oncology, online erschienen am 25.03.2021. Verfasst von Hiroshi Katoh und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We report a 65-year old female with advanced papillary thyroid carcinoma involving the critical vessels including common carotid artery (CCA).She initially refused surgery and lenvatinib (LEN) was used in neoadjuvant setting.Primary tumor effectively shrank by LEN without any critical adverse effect.Total thyroidectomy and modified neck dissection were curatively performed.Tumor invading into internal jugular vein exhibited remarkable response to LEN and was almost replaced with necrosis and fibrosis.CCA was surrounded by fibrosis but was smoothly dissected from tumor and preserved.The patient shows no sign of recurrence for 2 years after surgery at present.Neoadjuvant LEN treatment can be new option for locally advanced papillary thyroid carcinoma involving critical vessels, particularly CCA, to reduce risk of surgical morbidity.
Zitieren
APA
Katoh, H., Kajita, S., Yokota, M., Sengoku, N., & Sangai, T. (2020). Neoadjuvant Use of Lenvatinib in Locally Advanced Papillary Thyroid Carcinoma Involving Critical Vessels. International Journal of Endocrine Oncology, 7(3). https://doi.org/10.2217/ije-2020-0014
Vancouver
Katoh H, Kajita S, Yokota M, Sengoku N, Sangai T. Neoadjuvant Use of Lenvatinib in Locally Advanced Papillary Thyroid Carcinoma Involving Critical Vessels. International Journal of Endocrine Oncology. 2020;7(3). doi:10.2217/ije-2020-0014
BibTeX
@article{Katoh2020,
author = {Katoh, Hiroshi and Kajita, Sabine and Yokota, Mitsuo and Sengoku, Norihiko and Sangai, Takafumi},
title = {Neoadjuvant Use of Lenvatinib in Locally Advanced Papillary Thyroid Carcinoma Involving Critical Vessels},
journal = {International Journal of Endocrine Oncology},
year = {2020},
volume = {7},
number = {3},
doi = {10.2217/ije-2020-0014}
}
EUVIMED